Skip to main content
Quest Diagnostics

Myasthenia Gravis: How Antibody Testing Helps you in the Management of Your Patient

Myasthenia Gravis: How Antibody Testing Helps you in the Management of Your Patient

 

Learning Objectives:

  -  Overview of the pathophysiology of myasthenia Gravis (MG)

  -  Learn about the differential diagnosis and related disorders

  -  Understand the role of antibody testing in treatment decisions

  -  The role of LRP4 testing in MG

 

Authors: Sat Dev Batish, PhD and Michael K Racke, MD

Moderator: Amanda Backman 

Date:
May 11, 2021
Presenter(s):
Batish, Sat Dev and Racke, Michael K.
Moderator(s):
Amanda Backman

Related content

Publication
LRP4 antibody testing in myasthenia gravis
Test FAQ
Autoimmune Neurology
Conference Presentation
Comparison of Validated Neurological Outcome Instruments to Assess Myasthenia Gravis in Outpatients Receiving Long-Term Therapeutic Plasma Exchange: A Multicenter Quality Assessment Project

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.